Alternate Controller Enabled Insulin Infusion Pump
The Alternate Controller Enabled Insulin Infusion Pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient with basal and bolus drug delivery at set or variable rates, designed to reliably and securely communicate with external devices such as automated insulin dosing systems to allow insulin delivery commands to be received, executed, and confirmed. It is classified as FDA Class 2, requiring 510(k) premarket notification under regulation 880.5730 in the Clinical Chemistry specialty. The product code is QFG. It is not an implant and is not life-sustaining.
Research product code QFG in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- QFG
- Device Class
- FDA class 2
- Regulation Number
- 880.5730
- Medical Specialty
- Clinical Chemistry
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
Definition
An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to be received, executed, and confirmed. ACE insulin pumps are intended to be used both alone and in conjunction with digitally connected medical devices for the purpose of insulin delivery.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 28 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K261672 | twiist Automated Insulin Delivery (AID) System | Jun 17, 2026 | Substantially Equivalent | Deka Research and Development |
| K253976 | iLet ACE Pump | Apr 30, 2026 | Substantially Equivalent | Beta Bionics, Inc. |
| K253743 | MiniMed Flex pump | Mar 12, 2026 | Substantially Equivalent | Medtronic Minimed, Inc. |
| K253470 | MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894) | Jan 15, 2026 | Substantially Equivalent | Medtronic Minimed, Inc. |
| K253074 | Tandem Mobi insulin pump with interoperable technology | Nov 06, 2025 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K252770 | iLet ACE Pump | Sep 29, 2025 | Substantially Equivalent | Beta Bionics, Inc. |
| K250792 | t:slim X2 insulin pump with interoperable technology | Sep 24, 2025 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K251032 | MiniMed 780G insulin pump | Jul 01, 2025 | Substantially Equivalent | Medtronic Minimed, Inc. |
| K250930 | twiist system | Apr 02, 2025 | Substantially Equivalent | Deka Research & Development Corp. |
| K234027 | embecta Insulin Delivery System | Aug 30, 2024 | Substantially Equivalent | Embecta Medical I, LLC |
| K241078 | Tandem Mobi Insulin Pump with interoperable technology | Jul 26, 2024 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K241178 | DEKA ACE Pump System | May 24, 2024 | Substantially Equivalent | Deka Research and Development |
| K240309 | Tandem Mobi insulin pump with interoperable technology | Mar 21, 2024 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K233952 | DEKA ACE Pump System | Mar 13, 2024 | Substantially Equivalent | Deka Research and Development |
| K230545 | Inessa System | Dec 20, 2023 | Substantially Equivalent | Triple Jump Israel , Ltd. |
| K232380 | t:slim X2 Insulin Pump with Interoperable Technology | Nov 03, 2023 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K231826 | Omnipod 5 ACE Pump | Oct 18, 2023 | Substantially Equivalent | Insulet Corporation |
| K233044 | Tandem Mobi insulin pump with interoperable technology | Oct 05, 2023 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K213134 | Accu-Chek Solo micropump system with interoperable technology | Aug 10, 2023 | Substantially Equivalent | Roche Diabetes Care GmbH |
| K213536 | DEKA ACE Pump System | Jul 25, 2023 | Substantially Equivalent | Deka Research and Development |
| K223213 | Tandem Mobi Insulin Pump with Interoperable Technology | Jul 10, 2023 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K231485 | iLet® ACE Pump | Jun 21, 2023 | Substantially Equivalent | Beta Bionics, Inc. |
| K223846 | iLet® ACE Pump | May 19, 2023 | Substantially Equivalent | Beta Bionics, Inc. |
| K203234 | t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app) | Feb 15, 2022 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K203768 | Omnipod 5 ACE Pump (Pod) | Jan 27, 2022 | Substantially Equivalent | Insulet Corporation |
| K201214 | t:slim X2 Insulin Pump with Interoperable Technology | Jun 04, 2020 | Substantially Equivalent | Tandem Diabetes Care, Inc. |
| K191679 | Omnipod DASH Insulin Management System with interoperable technology | Sep 20, 2019 | Substantially Equivalent | Insulet Corporation |
| DEN180058 | t:slim X2 insulin pump with interoperable technology | Feb 14, 2019 | Unknown | Tandem Diabetes Care, Inc. |
FEI Numbers
This FDA classification entry is associated with 27 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 27 registration numbers. Click on an entry to view related FDA registrations.